Copyright: ©Author(s) 2026.
World J Stem Cells. Aug 26, 2026; 18(8): 120270
Published online Aug 26, 2026. doi: 10.4252/wjsc.120270
Published online Aug 26, 2026. doi: 10.4252/wjsc.120270
Figure 3 Effects of human umbilical cord-derived mesenchymal stem cells on epithelial-mesenchymal transition-related gene and protein expression in high glucose-treated HMrSV5 cells.
A: Epithelial cadherin mRNA; B: Vimentin mRNA; C: Alpha-smooth muscle actin mRNA; D: Transforming growth factor-beta1 mRNA levels detected via quantitative real-time polymerase chain reaction; E: Representative western blot bands; F-I: Quantitative analysis of protein expression: Epithelial cadherin (F); vimentin (G); alpha-smooth muscle actin (H); transforming growth factor-beta1 (I). Data are presented as mean ± SD. aP < 0.05 vs control; bP < 0.05 vs high glucose. hUC-MSCs: Human umbilical cord-derived mesenchymal stem cells; HG: High glucose; E-cadherin: Epithelial cadherin; α-SMA: Alpha-smooth muscle actin; TGF-β1: Transforming growth factor-beta1.
- Citation: Dong FX, Zheng LL, Nie K, Wan JX. Protective effect of hUC-MSCs regulating peritoneal mesothelial cell EMT through cGAS-STING signaling pathway in high glucose-induced peritoneal fibrosis. World J Stem Cells 2026; 18(8): 120270
- URL: https://www.wjgnet.com/1948-0210/full/v18/i8/120270.htm
- DOI: https://dx.doi.org/10.4252/wjsc.120270